Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.1 (
sulfatase
)
3,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously demonstrated that an acidic variant (B1) of lysosomal
arylsulfatase B
from transplanted human lung cancer is phosphorylated on its protein and carbohydrate moieties (Gasa, S., and Makita, A. (1983) J. Biol. Chem. 258, 5034-5039). The present study identifies that a
cAMP-dependent protein kinase
is responsible for phosphorylation of
arylsulfatase B
. The protein kinase activity toward the
sulfatase
was considerably higher in the transplanted lung cancer than in normal lung in the presence of cAMP. B enzyme purified from normal human liver was found to contain 0.6 mol/mol B enzyme, and protein kinase treatment added further 1.3 mol of Pi to give a single phosphopeptide (X). On the other hand, B1 enzyme purified from the transplanted human lung cancer which had been labeled in vivo with 32Pi revealed at least two phosphopeptides (X and Y). Assuming that the
sulfatase
from normal liver and lung cancer possesses the same number of available phosphorylation sites, phosphorylation of site X which was available only by deliberate phosphorylation of the native, ordinary B enzyme appears to be cancer-associated. Increasing phosphorylation of the
sulfatase
resulted in a maximum 50% elevation in
arylsulfatase
activity, followed by a decrease of the activity upon overphosphorylation, using an artificial substrate.
...
PMID:Phosphorylation of human lysosomal arylsulfatase B by cAMP-dependent protein kinase. Different sites of phosphorylation between normal and cancer tissues. 243 76
Since a lysosomal
arylsulfatase B
has been shown to be phosphorylated by a
cAMP-dependent protein kinase
(cAMP-PK) in transplantable human lung tumor, protein kinase isozymes were investigated in the tumor. Although the kinase of normal human lung comprised both type I and II isozymes at lower level, the tumor kinase was elevated in the activity and occupied almost exclusively by the type II which was responsible for the phosphorylation of
arylsulfatase B
. The isozyme deviation was also observed in the casein kinase of the tumor with predominance of type II in the tumor in contrast to the coexistence of both types I and II in normal lung.
...
PMID:Alterations of protein kinase isozymes in transplantable human lung cancer with special reference to the phosphorylation of arylsulfatase B. 282 63
Previous studies from this laboratory have demonstrated that arylsulfatase B (ASB) is phosphorylated by a protein kinase, which is the first finding of phosphorylation in lysosomal hydrolases. The present study was undertaken to characterize the sites of phosphorylation in
ASB
from transplanted human lung cancer and from normal human tissues, and to identify type of tumor protein kinase responsible for the phosphorylation of
ASB
. When
ASB
purified from liver and placenta was phosphorylated in vitro by a
cAMP-dependent protein kinase
, it gave a single tryptic phosphopeptide (X) and phosphothreonine. On the other hand, the tumor
ASB
which had been phosphorylated in vivo demonstrated two phosphopeptides X and Y. Since the tumor
ASB
had been shown to be phosphorylated both at threonine and serine residues, phosphorylation at threonine residue of peptide X, which is phosphorylated by a
cAMP-dependent protein kinase
, will be cancer-associated. Through photoaffinity labeling with a labeled cAMP analogue to detect regulatory subunits of
cAMP-dependent protein kinase
subtypes, it was found that the
cAMP-dependent protein kinase
in the transplanted lung tumor was largely type II which can be ascribed to the appearance of highly phosphorylated
ASB
in the tumor.
...
PMID:Protein phosphorylation of human lysosomal arylsulfatase B from normal and cancer tissues. 338 98
Many lysosomal hydrolases in cases of human cancer were found to be accompanied by acidic variant forms together with the major hydrolase components. Such variants were found to be phosphorylated not only at their carbohydrate moiety which contributes largely to their acidic property, but also at the protein moiety. We identified a
cAMP-dependent protein kinase
which is responsible for phosphorylation of
arylsulfatase B
. The protein kinase activity toward the
sulfatase
was considerably higher in transplanted lung cancer than in normal lung in the presence of cAMP. The B enzyme purified from normal human liver was found to contain 0.6mol of Pi/mol of B enzyme, and protein kinase treatment added a further 1.3mol Pi to give a single phosphopeptide (X) containing phosphothreonine. On the other hand, the B1 enzyme purified from transplanted human lung cancer which had been labeled in vivo with [32P] Pi revealed at least two phosphopeptides (X and Y). Assuming that the
sulfatase
from liver and lung cancer possesses the same number of available phosphorylation sites, phosphorylation of site X (Thr) which is available only by deliberate phosphorylation of the native, ordinary B enzyme, appears to be cancer-associated. Increased phosphorylation of the
sulfatase
resulted in a maximum 50% elevation in
arylsulfatase
activity, followed by a decrease in the activity upon overphosphorylation, using an artificial substrate.
...
PMID:[Phosphorylation of lysosomal hydrolases in human cancer and its significance]. 360 35